INVA
Innoviva IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.68B
P/E Ratio
3.63
EPS
$6.26
Beta
0.35
52W High
$25.14
52W Low
$16.52
50-Day MA
$22.86
200-Day MA
$21.01
Dividend Yield
—
Profit Margin
119.90%
Forward P/E
11.51
PEG Ratio
0.33
About Innoviva Inc
Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.
Fundamentals
| Revenue (TTM) | $420.69M |
| Gross Profit (TTM) | $311.74M |
| EBITDA | $192.70M |
| Operating Margin | 40.10% |
| Return on Equity | 50.70% |
| Return on Assets | 6.72% |
| Revenue/Share (TTM) | $5.99 |
| Book Value | $18.18 |
| Price-to-Book | 1.25 |
| Price-to-Sales (TTM) | 3.99 |
| EV/Revenue | 3.175 |
| EV/EBITDA | 2.08 |
| Quarterly Earnings Growth (YoY) | 590.00% |
| Quarterly Revenue Growth (YoY) | 10.60% |
| Shares Outstanding | $73.81M |
| Float | $69.19M |
| % Insiders | 0.99% |
| % Institutions | 108.03% |
Historical Volatility
HV 10-Day
23.85%
HV 20-Day
28.21%
HV 30-Day
25.16%
HV 60-Day
23.83%
HV Rank
54.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($35.50 target)
3
Buy1
SellMore HEALTHCARE Stocks
Data last updated: 6/13/2026